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Whole-exome sequencing has exploded on the scene as
a way of identifying disease mutations. Roach et al.
propose an even more powerful technique to zero in on
causative genetic variation, and their approach also gives
us some more basic information about the human
genome. Whole-genome sequences from a family of four
individuals, two parents and their two children were
analyzed. The children are both afﬂicted with Miller
syndrome and primary ciliary dyskinesia and had been
included as two of the cases in the paper by Ng et al.
(Nature Genetics 42, 30) that used whole-exome
sequencing to identify the Miller syndrome gene. Roach
et al. hone right in on the causative genes for both pheno-
types; the family-based approach vastly improves their
ability to sort through false-positive sequence variants,
signiﬁcantly enhances sequence accuracy, and reduces
the number of candidate genes that need to be considered
in the analysis to four. This analysis also lets them precisely
pinpoint sites of recombination and estimate the intergen-
erational mutation rate to be 1.1 3 108 per position per
haploid genome, which is quite a bit lower than previous
estimates made with the use of evolutionary data.
Roach et al. (2010) Analysis of genetic inheritance in a family
quartet by whole-genome sequencing. Science Express, in press.
Published online March 10, 2010. 10.1126/science.1186802.
The Mother-to-Child Transition
At the point of fertilization, gene products encoded by the
mother control development. This lasts until the point of
maternal-zygotic transition, at which time the zygotic
genome is activated. The mechanism by which the zygotic
genome is held inactive until the time of this transition is
unclear, so Vastenhouw et al. studied the chromatin marks
on the zygotic genome over this time period in zebraﬁsh
embryos. They mapped histone H3 trimethylation marks
and found that the maternal-zygotic transition is accom-
panied by major changes to these modiﬁcations that may
govern zygotic genome activation. The majority of genes
acquire an activating H3K4Me3 mark at the point of the
transition, including many inactive genes, which do not
have the H3K36me3 modiﬁcation that marks sites of tran-
scriptional elongation. These genes are not stably associ-
ated with RNA polymerase II, although the mechanism
by which they are maintained in a repressed state is
unclear. Other inactive genes, including many develop-1Department of Human Genetics, Emory University School of Medicine, Atlan
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modiﬁcation in addition to the activating H3K4Me3, and
this bivalent markmay poise them for activation while still
keeping them in a repressed state. In addition to allowing
us to better understand the basic biological underpinnings
of this point in development, the maternal-zygotic transi-
tion coincides with the formation of pluripotent cells, so
this line of research has implications for our understanding
of embryonic stem cells.
Vastenhouw et al. (2010) Chromatin signature of embryonic
pluripotency is established during genome activation. Nature
464, 922–926.
The Wide Reach of Cilia
Primary cilia are critical for proper development and main-
tenance of certain tissues, and defects in these nonmotile
cilia cause a range of human diseases, from malformations
in the brain to polycystic kidney disease and a variety of
disorders in between. Over the past few years, several
components of primary cilia have been identiﬁed, but
Kim et al. decided to take one step back and look for regu-
lators of ciliogenesis by the use of a large-scale screen. They
developed a quantitative ﬂuorescence-based assay for cilio-
genesis that makes use of a green ﬂuorescent protein–
tagged ciliary protein and evaluated the impact of several
thousand genes on ciliogenesis with the use of siRNAs.
They found 49 positive and negative regulators of ciliogen-
esis, and further investigation of these regulators led them
to uncover new connections between actin network
formation, endocytic recycling, and the formation of cilia.
They also investigated a new cellular structure, dubbed the
pericentrosomal preciliary compartment, that seems as
though it may provide a temporary reserve of building
blocks for cilium formation.
Kim et al. (2010) Functional genomic screen for modulators
of ciliogenesis and cilium length. Nature 464, 1048–1051.
Translating Genetic Variation to Gene Expression
We don’t all express the same amount of every gene, and
this is part of the reason that we are each unique. Gene-
expression differences could be inﬂuenced by sequence
variation, epigenetic regulation, or other variables
completely unrelated to the DNA, but the relative impor-
tance of each of these factors is unknown. Two groups
recently took a stab at ﬁguring out how much sequence
variation is likely to affect gene expression, by takingta, GA 30322, USA
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a genome-wide look at the relationship between genetic
variation and DNase I hypersensitivity sites and/or chro-
matin immunoprecipitation proﬁles. Together, their data
indicate that genetic variation can inﬂuence transcription
factor binding, chromatin structure, and gene expression.
McDaniell et al. show that these effects are heritable,
further supporting the attribution of the expression differ-
ences to sequence variation. Although sequence variation
does inﬂuence the expression of some genes, these genes
are actually in the minority, so this is not the end of the
story.
Kasowski et al. (2010 Variation in transcription factor
binding among humans. Science 328, 232–235.
McDaniell et al. (2010) Heritable individual-speciﬁc and
allele-speciﬁc chromatin signatures in humans. Science 328,
235–239.
Sorting through Mutations in a Cancer Genome
Now that it is feasible to sequence whole genomes, several
recent papers have reported comparisons of a cancer
genome relative to the constitutional genome sequence
of the affected individual. Some of the cancer-speciﬁc
mutations identiﬁed through these projects were undoubt-
edly involved in cancer development, but others are likely660 The American Journal of Human Genetics 86, 659–660, May 14,to have just gone along for the ride, and the task now is to
ﬁgure out which is which. To give themselves a leg up in
sorting through breast cancer mutations, Ding et al.
compared four whole-genome sequences derived from
the same patient with breast cancer: samples from her
peripheral blood, samples from the primary tumor, a xeno-
graft of the primary tumor, and a brain metastasis. This al-
lowed them to pick out the mutations and structural
changes that were speciﬁc to the tumor and then ascertain
which of these were maintained or lost during metastasis
and/or xenograft development. Not only are they able to
ﬁnd genetic changes that are gained or lost during tumor
development and metastasis, but the massively parallel
sequencing approach that they used to obtain their data
also allowed them to estimate the relative abundance of
each sequence as the tumor developed and metastasized,
an analysis that supports the idea that a minority of cells
from the mixed primary tumor went on to form the metas-
tasis. Although this approach doesn’t pinpoint exactly
which mutations are the most important at each stage of
the cancer, it does give them a global picture of the evolu-
tion of the cancer in a single individual.
Ding et al. (2010) Genome remodeling in a basal-like breast
cancer metastasis and xenograft. Nature 464, 999–1005.This Month in Our Sister JournalsWe Can Make it Better, Stronger, Faster.
Although a signiﬁcant fraction of individuals with idio-
pathic dilated cardiomyopathy (DCM) have a family
history of the disorder, the genetic heterogeneity to this
disorder makes it difﬁcult to identify an underlying cause.
Already, more than 30 genes have been identiﬁed for
DCM, which makes genetic testing for DCM expensive
and complicated. Zimmerman et al. have addressed this
problem through the development of a resequencing-based
array for DCM genetic testing that includes 19 genes, nine
more than previous testing arrays. This approach signiﬁ-
cantly reduces the cost and turnaround time of testing
and increases the likelihood that a relevant mutation will
be identiﬁed. When tested on 73 DCM patients for whom
no mutation had previously been identiﬁed, the approach
identiﬁed seven sequence variants of likely clinical signiﬁ-
cance in the new genes included on the array.
Zimmerman et al. (2010) A novel custom resequencing
array for dilated cardiomyopathy. Genetics in Medicine, in
press. Published online March 11, 2010. 10.1097/GIM.
0b013e3181d6f7c0.
You Can’t Get There from Here
In addition to binding CD4 on target cells, HIV uses one of
two different cell-surface chemokine receptors to enter
cells. During primary infections, HIV almost exclusivelyuses CCR5 as a coreceptor, but it can switch to use of
CXCR4 late in infection. Although HIV is a rapidly
mutating virus and only a small number of viral mutations
is needed to switch the coreceptor used by the virus, core-
ceptor switching does not occur as readily as might be pre-
dicted. To determine what barriers might prevent HIV cor-
eceptor switching, da Silva et al. compared a CCR5-using
parent strain of HIV and its CXCR4-using derivative.
They systematically engineered mutations from the
derived strain back into the parent strain singly and in
combinations and measured the ﬁtness of each in order
to quantify the epistatic effect of the mutations on viral
ﬁtness. They attempted to determine the minimal muta-
tional pathway that would be needed to get from the
CCR5-using to the CXCR4-adapted daughter strain and
found that some predicted steps along the way were selec-
tively disadvantageous, a fact that could constrain viral
adaptation and coreceptor switching. Because this process
is associated with disease progression, an understanding of
the mechanism by which HIV evolves to use a second cor-
eceptor could help us understand how to put a stop to this
wily virus.
da Silva et al. Fitness epistasis and constraints on adaptation
in a human immunodeﬁciency virus type 1 protein region.
Genetics, in press. Published online February 15, 2010.
10.1534/genetics.109.112458.2010
